These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36179555)

  • 1. Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease.
    Pelowski M; Spee BTM; Arato J; Dörflinger F; Ishizu T; Richard A
    Phys Life Rev; 2022 Dec; 43():32-95. PubMed ID: 36179555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creativity, art and brain: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Matthew Pelowski et al.
    Bogousslavsky J
    Phys Life Rev; 2023 Mar; 44():116-118. PubMed ID: 36634557
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in style as a diagnostic medical tool or a way to study creativity in art?: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Pelowski et al. (2022).
    Leder H; Crone JS
    Phys Life Rev; 2023 Sep; 46():52-55. PubMed ID: 37245452
    [No Abstract]   [Full Text] [Related]  

  • 4. From brain images to drawings - New insights informing the creativity-psychopathology debate: Commentary on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Pelowski et al.
    Benedek M; Fink A
    Phys Life Rev; 2023 Mar; 44():179-183. PubMed ID: 36773388
    [No Abstract]   [Full Text] [Related]  

  • 5. Bridging neurodegenerative diseases and artistic expressivity: The significance of testable models and causal inference: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Pelowski et al. (2022).
    Kathofer M; Leder H; Crone JS
    Phys Life Rev; 2023 Jul; 45():66-70. PubMed ID: 37167925
    [No Abstract]   [Full Text] [Related]  

  • 6. Can we "read" art…at all? A psychometric perspective on the possibility of measuring artwork attributes: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Pelowski et al. (2022).
    Myszkowski N
    Phys Life Rev; 2023 Mar; 44():48-50. PubMed ID: 36493628
    [No Abstract]   [Full Text] [Related]  

  • 7. Goldstein's 'catastrophic reactions' reinterpreted as neuroaesthetic 'signatures': Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Matthew Pelowski et al.
    Stahnisch FW
    Phys Life Rev; 2023 Mar; 44():91-93. PubMed ID: 36563478
    [No Abstract]   [Full Text] [Related]  

  • 8. No sound evidence supports the notion that we can "read" art: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Pelowski et al. (2022).
    Nadal M; Skov M
    Phys Life Rev; 2023 Mar; 44():110-112. PubMed ID: 36610203
    [No Abstract]   [Full Text] [Related]  

  • 9. Art as a window to altered perception? - A possible understanding of neurodegenerative diseases through the philosophy of Konrad Fiedler: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Matthew Pelowski et al.
    Hayn-Leichsenring GU
    Phys Life Rev; 2023 Mar; 44():160-162. PubMed ID: 36701911
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic potential of reading art in brain damage and the possible contribution of non-invasive brain stimulation: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Matthew Pelowski, Blanca T.M. Spee, et al.
    Slaby RJ; Cappa S; Cattaneo Z
    Phys Life Rev; 2023 Jul; 45():25-28. PubMed ID: 36931122
    [No Abstract]   [Full Text] [Related]  

  • 11. Art and the brain: a view from dementia.
    Gretton C; ffytche DH
    Int J Geriatr Psychiatry; 2014 Feb; 29(2):111-26. PubMed ID: 23925829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why would Parkinson's disease lead to sudden changes in creativity, motivation, or style with visual art?: A review of case evidence and new neurobiological, contextual, and genetic hypotheses.
    Lauring JO; Ishizu T; Kutlikova HH; Dörflinger F; Haugbøl S; Leder H; Kupers R; Pelowski M
    Neurosci Biobehav Rev; 2019 May; 100():129-165. PubMed ID: 30629980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are neurodegenerative disorders causing characteristic changes in visual artwork?: Commentary on "Can we really 'read' art to see the changing brain?" by M. Pelowski, B.T.M. Spee, J. Arato, F. Dörflinger, T. Ishizu, A. Richard.
    Treven M
    Phys Life Rev; 2023 Mar; 44():102-104. PubMed ID: 36586307
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease and changes in the appreciation of art: A comparison of aesthetic and formal evaluations of paintings between PD patients and healthy controls.
    Lauring JO; Pelowski M; Specker E; Ishizu T; Haugbøl S; Hollunder B; Leder H; Stender J; Kupers R
    Brain Cogn; 2019 Nov; 136():103597. PubMed ID: 31491732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-controlled study of altered visual art production in Alzheimer's and FTLD.
    Rankin KP; Liu AA; Howard S; Slama H; Hou CE; Shuster K; Miller BL
    Cogn Behav Neurol; 2007 Mar; 20(1):48-61. PubMed ID: 17356345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Artistic creativity and dementia].
    Sellal F; Musacchio M
    Psychol Neuropsychiatr Vieil; 2008 Mar; 6(1):57-66. PubMed ID: 18364297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.